Patents by Inventor Stephanie Marie Varjan

Stephanie Marie Varjan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
    Publication number: 20240148673
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described, the prodrugs having a half-life of less than one minute, and the compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
    Publication number: 20240016734
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described and the compositions having enhanced active component permeation properties are described as being administered with specific residence times.
    Type: Application
    Filed: June 14, 2023
    Publication date: January 18, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20230138361
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: June 8, 2022
    Publication date: May 4, 2023
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
    Publication number: 20220160657
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described, the prodrugs having a half-life of less than one minute, and the compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: December 13, 2021
    Publication date: May 26, 2022
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Pharmaceutical compositions with enhanced permeation
    Patent number: 11273131
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: March 15, 2022
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Enhanced delivery epinephrine compositions
    Patent number: 11191737
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: December 7, 2021
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Enhanced delivery epinephrine compositions
    Patent number: 11160771
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: November 2, 2021
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
    Publication number: 20190022022
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 24, 2019
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
    Publication number: 20190022023
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 24, 2019
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
    Publication number: 20180200198
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: October 3, 2017
    Publication date: July 19, 2018
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20180125977
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: September 27, 2017
    Publication date: May 10, 2018
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20180104195
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: October 23, 2017
    Publication date: April 19, 2018
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
    Publication number: 20170348251
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: May 4, 2017
    Publication date: December 7, 2017
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
    Publication number: 20170290776
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: May 4, 2017
    Publication date: October 12, 2017
    Applicant: MONOSOL RX, LLC
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki